Alnylam Pharmaceuticals
ALNY
#430
Rank
ยฃ40.74 B
Marketcap
ยฃ308.43
Share price
2.02%
Change (1 day)
54.93%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company